PT87668A - Canine coronavirus vaccine - Google Patents

Canine coronavirus vaccine

Info

Publication number
PT87668A
PT87668A PT8766888A PT8766888A PT87668A PT 87668 A PT87668 A PT 87668A PT 8766888 A PT8766888 A PT 8766888A PT 8766888 A PT8766888 A PT 8766888A PT 87668 A PT87668 A PT 87668A
Authority
PT
Portugal
Prior art keywords
ccv
canine coronavirus
vaccine
coronavirus vaccine
cell
Prior art date
Application number
PT8766888A
Other languages
English (en)
Other versions
PT87668B (pt
Inventor
Michael Alonzo Gill
Stephen W May
Original Assignee
Norden Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Lab Inc filed Critical Norden Lab Inc
Publication of PT87668A publication Critical patent/PT87668A/pt
Publication of PT87668B publication Critical patent/PT87668B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT87668A 1987-06-08 1988-06-07 Processo de preparacao de uma vacina contra coronavirus canino PT87668B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,437 US4904468A (en) 1987-06-08 1987-06-08 Canine coronavirus vaccine

Publications (2)

Publication Number Publication Date
PT87668A true PT87668A (pt) 1988-07-01
PT87668B PT87668B (pt) 1992-09-30

Family

ID=22022943

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87668A PT87668B (pt) 1987-06-08 1988-06-07 Processo de preparacao de uma vacina contra coronavirus canino

Country Status (20)

Country Link
US (1) US4904468A (pt)
EP (1) EP0295057B1 (pt)
JP (1) JP2655876B2 (pt)
KR (1) KR970000233B1 (pt)
AT (1) ATE91902T1 (pt)
AU (1) AU612151B2 (pt)
CA (1) CA1337267C (pt)
DE (1) DE3882599T2 (pt)
DK (1) DK175410B1 (pt)
ES (1) ES2058283T3 (pt)
FI (1) FI87531C (pt)
HU (1) HU203984B (pt)
IE (1) IE63006B1 (pt)
IL (1) IL86635A0 (pt)
MY (1) MY103575A (pt)
NO (1) NO176004C (pt)
NZ (1) NZ224865A (pt)
PH (1) PH27018A (pt)
PT (1) PT87668B (pt)
ZA (1) ZA884040B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
ZA903142B (en) * 1989-05-03 1991-02-27 Akzo Nv Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
SG46225A1 (en) * 1990-04-24 1998-02-20 Flustat Pty Limited Oral vaccine comprising antigen surface-associated with red blood cells
US6372224B1 (en) * 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
ATE256746T1 (de) * 1991-04-25 2004-01-15 Akzo Nobel Nv Subeinheits-impfstoff gegen hundecoronavirus
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
CA2135200C (en) * 1992-05-08 2001-03-27 Timothy J. Miller Canine coronavirus s gene and uses therefor
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
DE602005025649D1 (de) * 2005-10-26 2011-02-10 Canio Buonavoglia Pantropisches Hundecoronavirus
US7761389B2 (en) 2007-08-23 2010-07-20 Gm Global Technology Operations, Inc. Method for anomaly prediction of battery parasitic load
WO2011047158A1 (en) * 2009-10-14 2011-04-21 The Board Of Regents For Oklahoma State University Isolation of a virus related to canine parvovirus-2 from a raccoon
CN104812893B (zh) 2012-11-22 2018-08-03 旭化成医疗株式会社 高感染滴度的细小病毒的生产方法
CN106290880B (zh) * 2015-05-27 2019-01-04 江苏雷森生物科技有限公司 一种用于犬冠状病毒的免疫层析用试剂组合物及检测方法
EP3372677B8 (en) 2015-11-06 2019-09-25 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer and high purity
CN110903387A (zh) * 2019-12-17 2020-03-24 吉林省纽卓莱生物科技有限责任公司 一种犬冠状病毒免疫球蛋白F(ab′)2及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
DE3650289T2 (de) * 1985-03-29 1995-08-10 British Tech Group Spike-protein des virus der infektiösen bronchitis.

Also Published As

Publication number Publication date
ZA884040B (en) 1989-09-27
EP0295057A3 (en) 1989-12-27
DK301588A (da) 1988-12-09
DK301588D0 (da) 1988-06-02
KR970000233B1 (ko) 1997-01-08
IE881689L (en) 1988-12-08
IE63006B1 (en) 1995-03-22
FI882689A0 (fi) 1988-06-07
NO176004B (no) 1994-10-10
IL86635A0 (en) 1988-11-30
PT87668B (pt) 1992-09-30
FI882689A (fi) 1988-12-09
DE3882599T2 (de) 1994-02-10
EP0295057B1 (en) 1993-07-28
NO176004C (no) 1995-01-18
FI87531C (fi) 1993-01-25
HU203984B (en) 1991-11-28
DK175410B1 (da) 2004-09-27
CA1337267C (en) 1995-10-10
PH27018A (en) 1993-02-01
ES2058283T3 (es) 1994-11-01
JPS63316739A (ja) 1988-12-26
AU1747688A (en) 1988-12-08
DE3882599D1 (de) 1993-09-02
KR890000105A (ko) 1989-03-11
NZ224865A (en) 1990-12-21
HUT46858A (en) 1988-12-28
JP2655876B2 (ja) 1997-09-24
US4904468A (en) 1990-02-27
NO882500D0 (no) 1988-06-07
FI87531B (fi) 1992-10-15
EP0295057A2 (en) 1988-12-14
ATE91902T1 (de) 1993-08-15
AU612151B2 (en) 1991-07-04
MY103575A (en) 1993-08-28
NO882500L (no) 1988-12-09

Similar Documents

Publication Publication Date Title
ATE91902T1 (de) Hundecoronavirus-impfstoff.
ES2042751T3 (es) Nuevo procedimiento para la purificacion de viriones de la hepatitis a.
DE69426051D1 (de) Infektiösen Bronchitis Virus 4/91 enthaltender Geflügel-Impfstoff
DK0465204T3 (da) Vaccine mod Lyme sygdom
NZ195184A (en) Live feline infectious peritonitis (fip) virus vaccine; fip virus atcc no.vr-2004
DE3853672D1 (de) Nichtzurückschlagende RNS-Viren.
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
DE69103130D1 (de) Zellfreies Marekskrankheitvirus-Vakzin.
AU3115189A (en) Live combination vaccine
DE69210346D1 (de) Atmungskrankheitimpfstoff für Katzen
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
ES2084587T3 (es) Arn virus no revertientes.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920312

PC3A Transfer or assignment

Free format text: 960718 PFIZER INC. US

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20070912

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080607